H. Lundbeck Future Growth
Future criteria checks 1/6
H. Lundbeck is forecast to grow earnings and revenue by 9.8% and 2.8% per annum respectively. EPS is expected to grow by 10.6% per annum. Return on equity is forecast to be 14.3% in 3 years.
Key information
9.8%
Earnings growth rate
10.6%
EPS growth rate
Pharmaceuticals earnings growth | 15.3% |
Revenue growth rate | 2.8% |
Future return on equity | 14.3% |
Analyst coverage | Good |
Last updated | 20 Aug 2024 |
Recent future growth updates
Recent updates
Investors Interested In H. Lundbeck A/S' (CPH:HLUN B) Earnings
Jul 01These 4 Measures Indicate That H. Lundbeck (CPH:HLUN B) Is Using Debt Safely
Jun 05H. Lundbeck (CPH:HLUN B) Will Pay A Larger Dividend Than Last Year At DKK0.70
Mar 07H. Lundbeck (CPH:HLUN B) Has Announced That It Will Be Increasing Its Dividend To DKK0.70
Feb 22H. Lundbeck A/S Just Missed Earnings - But Analysts Have Updated Their Models
Feb 10Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 23,332 | 3,986 | 5,293 | 5,828 | 9 |
12/31/2025 | 22,426 | 3,525 | 4,681 | 5,367 | 10 |
12/31/2024 | 21,659 | 3,296 | 3,958 | 4,600 | 2 |
3/31/2024 | 20,156 | 2,416 | 4,145 | 4,663 | N/A |
12/31/2023 | 19,912 | 2,290 | 3,579 | 4,080 | N/A |
9/30/2023 | 19,614 | 2,467 | 3,528 | 4,426 | N/A |
6/30/2023 | 19,381 | 2,479 | 3,523 | 4,457 | N/A |
3/31/2023 | 18,918 | 2,384 | 3,292 | 4,102 | N/A |
12/31/2022 | 18,246 | 1,916 | 2,699 | 3,519 | N/A |
9/30/2022 | 17,619 | 1,603 | 2,051 | 2,615 | N/A |
6/30/2022 | 16,913 | 1,236 | 1,744 | 2,313 | N/A |
3/31/2022 | 16,398 | 1,109 | 1,344 | 1,959 | N/A |
12/31/2021 | 16,299 | 1,318 | 1,660 | 2,272 | N/A |
9/30/2021 | 16,521 | 1,873 | 2,405 | 2,949 | N/A |
6/30/2021 | 16,971 | 1,965 | 2,379 | 2,912 | N/A |
3/31/2021 | 17,381 | 2,110 | 3,263 | 3,757 | N/A |
12/31/2020 | 17,672 | 1,581 | 3,359 | 3,837 | N/A |
9/30/2020 | 17,818 | 904 | 2,713 | 3,171 | N/A |
6/30/2020 | 17,490 | 1,242 | 2,910 | 3,354 | N/A |
3/31/2020 | 17,366 | 1,507 | 1,502 | 1,960 | N/A |
12/31/2019 | 17,036 | 2,313 | 2,165 | 2,609 | N/A |
9/30/2019 | 16,811 | 3,091 | 3,210 | 3,621 | N/A |
6/30/2019 | 17,309 | 3,395 | 2,736 | 3,462 | N/A |
3/31/2019 | 17,766 | 3,606 | 4,100 | 4,815 | N/A |
12/31/2018 | 18,117 | 3,907 | 5,277 | 5,981 | N/A |
9/30/2018 | 18,313 | 3,806 | 5,057 | 5,922 | N/A |
6/30/2018 | 18,028 | 3,627 | 5,368 | 6,197 | N/A |
3/31/2018 | 17,608 | 3,236 | 4,629 | 5,397 | N/A |
12/31/2017 | 17,234 | 2,624 | N/A | 4,045 | N/A |
9/30/2017 | 17,007 | 2,544 | N/A | 3,731 | N/A |
6/30/2017 | 16,607 | 1,988 | N/A | 3,551 | N/A |
3/31/2017 | 16,075 | 1,612 | N/A | 3,420 | N/A |
12/31/2016 | 15,634 | 1,211 | N/A | 3,126 | N/A |
9/30/2016 | 15,202 | 290 | N/A | 4,158 | N/A |
6/30/2016 | 14,923 | -1,289 | N/A | 2,755 | N/A |
3/31/2016 | 14,801 | -5,427 | N/A | 936 | N/A |
12/31/2015 | 14,594 | -5,694 | N/A | 197 | N/A |
9/30/2015 | 14,108 | -5,879 | N/A | -1,330 | N/A |
6/30/2015 | 13,625 | -4,615 | N/A | -464 | N/A |
3/31/2015 | 13,444 | -565 | N/A | 1,379 | N/A |
12/31/2014 | 13,468 | -153 | N/A | 1,610 | N/A |
9/30/2014 | 13,808 | 503 | N/A | 2,601 | N/A |
6/30/2014 | 14,181 | 765 | N/A | 2,095 | N/A |
3/31/2014 | 14,269 | 119 | N/A | 2,982 | N/A |
12/31/2013 | 15,258 | 855 | N/A | 3,760 | N/A |
9/30/2013 | 15,516 | 1,036 | N/A | 2,931 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HLUN B's forecast earnings growth (9.8% per year) is above the savings rate (1%).
Earnings vs Market: HLUN B's earnings (9.8% per year) are forecast to grow slower than the Danish market (14.1% per year).
High Growth Earnings: HLUN B's earnings are forecast to grow, but not significantly.
Revenue vs Market: HLUN B's revenue (2.8% per year) is forecast to grow slower than the Danish market (10.9% per year).
High Growth Revenue: HLUN B's revenue (2.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HLUN B's Return on Equity is forecast to be low in 3 years time (14.3%).